2m 2m 2m 2m 2m 2m 2m
ACUMEN PHARMA (ABOS)
NASDAQ
$2.55-$0.10 (-3.60%)
Price as of Jul 14, 2026 5:27 PM EDT- $190.7MMarket Cap
- 77.18%1-Year Change
- BiotechnologyIndustry
ACUMEN PHARMA (ABOS)
$2.55-$0.10 (-3.60%)
ABOS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.64 | ||
Change | +$0.01 (+0.38%) | ||
Open | $2.59 | ||
High | $2.72 | ||
Low | $2.57 | ||
Previous Close | $2.63 | ||
Volume | 407,078 | ||
30-Day Average Volume | 709,933 | ||
1-Week Change | -1.12% | ||
1-Month Change | 11.39% | ||
1-Year Change | 77.18% | ||
3-Year Change | -56.86% | ||
5-Year Change | -86.06% | ||
Fundamentals | |||
Shares Outstanding | 72.2M | ||
Total Assets | $133.6M | ||
Market Cap | $190.7M | ||
Enterprise Value | $169.9M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$20.7M | ||
Free Cash Flow | -$24.1M | ||
EBIT | -$19.7M | ||
EBITDA | -$19.7M | ||
Net Working Capital | $103.9M | ||
EPS | -$0.33 | ||
Enterprise Value/EBITDA | -9 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -8 | ||
PEG | -0 | ||
Price/Free Cash Flow | -8 | ||
Price/Operating Cash Flow | -8 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue